P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY by Khadadah, F., Turkina, A. G., Lomaia, E., Morozova, E. V., Shukhov, O. A., Petrova, A., Chitanava, T., Vlasova, J. J., Kuzmina, E., Nemchenko, I., Chelysheva, E. Y., Bykova, A., Gurianova, M., Xenocostas, A., Busque, L., Jamani, K., Cerquozzi, S., Kuruvilla, P., Kaedbey, R., Leber, B., Assouline, S., Kim, D. D. H.

Get full text

P718: ASCIMINIB MANAGED‐ACCESS PROGRAM (MAP) IN RUSSIA by Shukhov, O., Turkina, A., Lomaia, E., Morozova, E., Petrova, A., Chitanava, T., Vlasova, Y., Chelysheva, E., Kuzmina, E., Nemchenko, I., Bykova, A., Gurianova, M., Kohno, A., Parovichnikova, E.

Get full text